Canopy Growth Corporation
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Luc Mongeau
- Full Time Employees
- 1,128
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 1 Hershey Drive Smiths Falls ON Canada K7A 0A8
- IPO Date
- Apr 7, 2014
- CIK
- 0001737927
- Website
- canopygrowth.com
- Similar Companies
- Business
- Canopy Growth Corporation is a leading global diversified cannabis company engaged in the cultivation, production, and sale of cannabis and cannabinoid-based products. The company offers an extensive portfolio including dried cannabis flower, pre-rolls, oils, softgels, edibles, and beverages, catering to both medical and recreational markets. Its core brands include Tweed, 7ACRES, DOJA, Deep Space, Claybourne, and medical cannabis through its subsidiary Storz & Bickel GmbH & Co. KG, which specializes in cannabis vaporization devices. Canopy operates large-scale GMP-certified indoor and greenhouse cultivation facilities primarily in Canada, with significant operations in the United States, Germany, the United Kingdom, and emerging markets in Australia, Denmark, Peru, and Brazil. Founded in 2013 and headquartered in Smiths Falls, Ontario, Canada, the company focuses on rigorous quality assurance, genetic research, and innovative product development. In the past two years, Canopy Growth has strategically sharpened its operational focus by divesting non-cannabis businesses and adopting an asset-light, brand-driven model to reduce complexity and cost structure. The company has advanced its product innovation with launches such as the advanced all-in-one vape devices featuring CCELL technology under the Tweed and 7ACRES brands to capture demand in premium vaporization formats. Financially, Canopy has improved stability by reducing costs, cash burn, and debt, while targeting positive adjusted EBITDA. It has made significant operational shifts including reallocating its Kelowna DOJA operations towards specialized medical cannabis cultivation and expanding into the wellness market with hemp-derived products under initiatives like Wana Wellness. Canopy also maintains a strategic option to acquire Acreage Holdings in the US, pending federal legalization, positioning it for accelerated entry into the American cannabis market. Canopy Growth's comprehensive range of cannabis products, global geographic footprint, and recent emphasis on operational efficiency and innovation underpin its role as a market leader in the cannabis industry. The company continues to focus on premium and mainstream cannabis products designed to improve lives while pursuing growth through strategic partnerships, focused market expansion, and advanced product offerings. It employs approximately 960 people and reported revenue growth and margin improvements in its Canadian cannabis segment amid ongoing cost reduction efforts. Its headquarters remain at 1 Hershey Drive, Smiths Falls, Ontario.
3 Top Marijuana Stocks to Watch in July 2026
Canopy Growth Announces Participation at Upcoming Canaccord Genuity Growth Conference
President Trump's Major Marijuana Move: What It Means for Canopy Growth, Green Thumb, and Tilray
3 Canadian Marijuana Stocks For Better Investing And Trading 2026
Why Canopy Growth Corporation (CGC) Dipped More Than Broader Market Today
Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know
Is Canopy Growth Stock Finally Worth Buying After Losing 99% of Its Value?
Canopy Growth Corporation (CGC) Declines More Than Market: Some Information for Investors
Canopy Growth: Is Another Reverse Stock Split Inevitable?
Top Canadian Marijuana Stock Picks For Investors Today
Could Canopy Growth Stock Deliver a 4X Gain? 1 Analyst Thinks So.
Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: Here's Why
Cannabis's 280E Tax Trap May Finally Break. We've Heard That Before.
Canopy Growth's Medical Marijuana Sales Are Soaring. Is the Beaten-Down Stock Ready to Rebound?
Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It
Leading Canadian Marijuana Stocks Showing Momentum in 2026
Canopy Growth Corporation (CGC) Dips More Than Broader Market: What You Should Know
3 Marijuana Stocks Investors Can See Returns On Before The End Of The Year
Canopy Growth Bought Time, Not A Higher Rating
CGC Q4 Earnings Call Focuses on EBITDA Path